GB712595A - New pyrimidines and processes for their production - Google Patents

New pyrimidines and processes for their production

Info

Publication number
GB712595A
GB712595A GB31697/52A GB3169752A GB712595A GB 712595 A GB712595 A GB 712595A GB 31697/52 A GB31697/52 A GB 31697/52A GB 3169752 A GB3169752 A GB 3169752A GB 712595 A GB712595 A GB 712595A
Authority
GB
United Kingdom
Prior art keywords
pyrimidine
diamino
chlorophenyl
derivative
butylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB31697/52A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc SA
Original Assignee
Rhone Poulenc SA
Societe des Usines Chimiques Rhone Poulenc SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc SA, Societe des Usines Chimiques Rhone Poulenc SA filed Critical Rhone Poulenc SA
Publication of GB712595A publication Critical patent/GB712595A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention comprises pyrimidine derivatives, having amoebicidal activity, of the general formula <FORM:0712595/IV (b)/1> and their salts, wherein Z represents a monovalent primary, secondary or tertiary amino radical, and X and X1 are the same or different and are hydrogen or chlorine or a methoxy, amino, nitro or cyano radical. Z is preferably a dialkyl amino radical in which the alkyl group contains from 1 to 5 carbon atoms, a piperidino, hexamethyleneimino or pyrrolidino radical. The compounds may be obtained (a) by reacting ammonia or a primary or secondary amine with a derivative of the formula <FORM:0712595/IV (b)/2> where Hal is halogen and R is hydrogen or an acyl radical; (b) by reacting ammonia with a derivative of the formula <FORM:0712595/IV (b)/3> (c) when Z represents -NH2, by reacting ammonia with the correspondingly 5-substituted 2,4,6-trihalogeno-pyrimidine or 2-amino- or 2-acetamido-4,6-dihalogenopyrimidine; or (d) by introducing one or more substituents at X and X1 of a 2,4,6-triamino-5-phenylpyrimidine. In methods (a) and (b), the reaction is effected above 150 DEG C. in the presence of a solvent such as ethanol. In the examples: (1) 2,4-diamino-5 - (41 - chlorophenyl) - 6 - di - n - butylamino - pyrimidine is prepared by heating di-n-butyl-amine with 2,4-diamino-5-(41-chlorophenyl)-6-chloropyrimidine in ethanol in an autoclave: by similar methods are prepared:-(2) the 6-dimethylamino, (3) the 6-diethylamino, (4) the 6-di-n-propylamino, (5) the 6-n-butylamino, (6) the 6-piperidino, (7) the 6-hexamethylene-imino, (8) the 6-pyrrolidino and (9) the 6-di-n-pentylamino derivatives and (10) 2,4-diamino-5-(31,41 - dichlorophenyl) - 6 - di - n - butylamino-pyrimidine: (11) 2,4,6-triamino-5-(41-chlorophenyl)-pyrimidine is prepared from ammonia and 2 - acetamido - 4,6 - dichloro - 5 - (41 - chlorophenyl)-pyrimidine: (12) 2,4,6-triamino-5-phenyl-pyrimidine is prepared from ammonia and 2,4-diamino-5-phenyl-6-chloropyrimidine and is converted into the 5-(41-nitrophenyl) derivative by the action of potassium nitrate in conc. sulphuric acid; by reduction of this nitro derivative with Adams platinum catalyst, 2,4,6 - triamino - 5 - (41-aminophenyl) - pyrimidine is formed and may be converted into the 5-(41-cyanophenyl) derivative by Sandmeyer's reaction: (13) the monohydrochloride of 2,4-diamino - 5 - phenyl - 6 - di - n - butylamino pyrimidine is prepared by adding to dry HCl in ether the product obtained by heating di-n-butylamine with 2,4-diamino-5-phenyl-6-chloropyrimidine; nitrating as in (12) yields the 5-(41-nitrophenyl) derivative: (14) the product of example (1) is obtained by heating ammonia with 2 - amino - 4 - chloro - 5 - (41 - chlorophenyl) - 6 - di - n - butylamino-pyrimidine, which itself is obtained by heating excess di-n-butylamine with 2-acetamido-4,6-dichloro-5-(41 - chlorophenyl) - pyrimidine. Specification 710,070 is referred to.
GB31697/52A 1952-01-30 1952-12-15 New pyrimidines and processes for their production Expired GB712595A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR712595X 1952-01-30

Publications (1)

Publication Number Publication Date
GB712595A true GB712595A (en) 1954-07-28

Family

ID=9080415

Family Applications (1)

Application Number Title Priority Date Filing Date
GB31697/52A Expired GB712595A (en) 1952-01-30 1952-12-15 New pyrimidines and processes for their production

Country Status (1)

Country Link
GB (1) GB712595A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014517016A (en) * 2011-06-10 2014-07-17 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング Pyrimidine having BTK inhibitory activity and composition of pyrimidine compound and method for producing the same

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014517016A (en) * 2011-06-10 2014-07-17 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング Pyrimidine having BTK inhibitory activity and composition of pyrimidine compound and method for producing the same
US9580449B2 (en) 2011-06-10 2017-02-28 Merck Patent Gmbh Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity
US10016448B2 (en) 2011-06-10 2018-07-10 Merck Patent Gmbh Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity
US10413562B2 (en) 2011-06-10 2019-09-17 Merck Patent Gmbh Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity

Similar Documents

Publication Publication Date Title
US3272811A (en) Dihydrothieno-[3, 4-d]-pyrimidines
US3255202A (en) Process for the preparation of 2-(acylamidoalkyl)benzimidazoles
Elion et al. The direct thiation of uracils
US3632807A (en) Process for the preparation of 2-chloro-pyridine and its derivatives
US3101336A (en) Heterocyclic substituted biguanides and cyanoguanidines
LEONARD et al. PREPARATION OF 4-MERCAPTO AND 4-AMINO QUINAZOLINES1
GB1094205A (en) Process for the preparation of amino-acid surface active agents
Russell et al. A Synthesis of 4-Amino-2-thiopyrimidines
GB901749A (en) New 2-substituted pyrimidines
GB712595A (en) New pyrimidines and processes for their production
Rose 663. New syntheses based on 5-aminopyrimidines
GB727151A (en) Improvements in derivatives of pyrimidine and methods of making the same
US3029241A (en) Phenylpbperazinylacyl anilines
ES418113A1 (en) Piperazino-pyrimidines process for their preparation and use
GB583815A (en) New pyrimidine compounds
GB777544A (en) Water soluble organic copper compounds and a process for their production
GB774095A (en) Improvements in or relating to pyrimidine compounds
US3629261A (en) Chloropyrimidine derivatives
GB860423A (en) Production of compounds of the pyrimidine series
GB741667A (en) New pyrimidine derivatives
GB810846A (en) New pyrimidine compounds and processes for producing the same
GB938646A (en) New piperazine derivatives
US4321202A (en) 1-Methyl-2(alkylimino)pyrrolidines and 1-methyl 2(cycloalkylimino) pyrrolidines
GB744867A (en) Improvements relating to 2-substituted-mercapto-4-amino-6-disubstituted-aminopyrimidines and acid addition salts thereof
US3591589A (en) 6-dialkylaminoalkoxy - 2-aryl-4-chloropyrimidines and 6-dialkylaminoalkylthio-2-aryl-4-chloropyrimidines